» Articles » PMID: 28275217

Identification of Proteins Interacting with Cytoplasmic High-Mobility Group Box 1 During the Hepatocellular Response to Ischemia Reperfusion Injury

Overview
Journal Int J Mol Sci
Publisher MDPI
Date 2017 Mar 10
PMID 28275217
Citations 6
Authors
Affiliations
Soon will be listed here.
Abstract

Ischemia/reperfusion injury (IRI) occurs inevitably in liver transplantations and frequently during major resections, and can lead to liver dysfunction as well as systemic disorders. High-mobility group box 1 (HMGB1) plays a pathogenic role in hepatic IRI. In the normal liver, HMGB1 is located in the nucleus of hepatocytes; after ischemia reperfusion, it translocates to the cytoplasm and it is further released to the extracellular space. Unlike the well-explored functions of nuclear and extracellular HMGB1, the role of cytoplasmic HMGB1 in hepatic IRI remains elusive. We hypothesized that cytoplasmic HMGB1 interacts with binding proteins involved in the hepatocellular response to IRI. In this study, binding proteins of cytoplasmic HMGB1 during hepatic IRI were identified. Liver tissues from rats with warm ischemia reperfusion (WI/R) injury and from normal rats were subjected to cytoplasmic protein extraction. Co-immunoprecipitation using these protein extracts was performed to enrich HMGB1-protein complexes. To separate and identify the immunoprecipitated proteins in eluates, 2-dimensional electrophoresis and subsequent mass spectrometry detection were performed. Two of the identified proteins were verified using Western blotting: betaine-homocysteine -methyltransferase 1 (BHMT) and cystathionine γ-lyase (CTH). Therefore, our results revealed the binding of HMGB1 to BHMT and CTH in cytoplasm during hepatic WI/R. This finding may help to better understand the cellular response to IRI in the liver and to identify novel molecular targets for reducing ischemic injury.

Citing Articles

Muscone improves hypoxia/reoxygenation (H/R)-induced neuronal injury by blocking HMGB1/TLR4/NF-κB pathway modulating microRNA-142.

Ren W, Zhao F, Han Y, Liu Z, Zhai J, Jia K PeerJ. 2022; 10:e13523.

PMID: 35860039 PMC: 9290999. DOI: 10.7717/peerj.13523.


Modification of mesenchymal stem cells by HMGB1 promotes the activity of Cav3.2 T-type calcium channel via PKA/β-catenin/γ-cystathionase pathway.

Wu H, Xie X, Sun M, Chen M, Tao X, Fang X Stem Cell Res Ther. 2022; 13(1):4.

PMID: 35012644 PMC: 8744322. DOI: 10.1186/s13287-021-02677-z.


Aucubin Attenuates Liver Ischemia-Reperfusion Injury by Inhibiting the HMGB1/TLR-4/NF-κB Signaling Pathway, Oxidative Stress, and Apoptosis.

Zhang S, Feng Z, Gao W, Duan Y, Fan G, Geng X Front Pharmacol. 2020; 11:544124.

PMID: 33013386 PMC: 7506056. DOI: 10.3389/fphar.2020.544124.


The role of dendritic cells regulated by HMGB1/TLR4 signalling pathway in myocardial ischaemia reperfusion injury.

Xue J, Ge H, Lin Z, Wang H, Lin W, Liu Y J Cell Mol Med. 2019; 23(4):2849-2862.

PMID: 30784177 PMC: 6433676. DOI: 10.1111/jcmm.14192.


High-Mobility Group Box-1 and Liver Disease.

Gaskell H, Ge X, Nieto N Hepatol Commun. 2018; 2(9):1005-1020.

PMID: 30202816 PMC: 6128227. DOI: 10.1002/hep4.1223.


References
1.
Yuan S, Kevil C . Nitric Oxide and Hydrogen Sulfide Regulation of Ischemic Vascular Remodeling. Microcirculation. 2015; 23(2):134-45. PMC: 6939643. DOI: 10.1111/micc.12248. View

2.
Vizcaino J, Csordas A, Del-Toro N, Dianes J, Griss J, Lavidas I . 2016 update of the PRIDE database and its related tools. Nucleic Acids Res. 2015; 44(D1):D447-56. PMC: 4702828. DOI: 10.1093/nar/gkv1145. View

3.
Huebener P, Gwak G, Pradere J, Quinzii C, Friedman R, Lin C . High-mobility group box 1 is dispensable for autophagy, mitochondrial quality control, and organ function in vivo. Cell Metab. 2014; 19(3):539-47. PMC: 4099361. DOI: 10.1016/j.cmet.2014.01.014. View

4.
Li S, Sun P, Williams J, Kao T . Identification of the self-incompatibility locus F-box protein-containing complex in Petunia inflata. Plant Reprod. 2014; 27(1):31-45. DOI: 10.1007/s00497-013-0238-3. View

5.
Paul B, Snyder S . Neurodegeneration in Huntington's disease involves loss of cystathionine γ-lyase. Cell Cycle. 2014; 13(16):2491-3. PMC: 4614824. DOI: 10.4161/15384101.2014.950538. View